Is ACH or BTMD more profitable?

biote has a net margin of -1.08% compared to Accendra Health's net margin of -6.72%. Accendra Health's return on equity of -4.02% beat biote's return on equity. Company Net Margins Return on Equity Return on Assets Accendra Health -6.72% -4.02% -0.80% biote -1.08% -8.84% 4.64%

Does the media prefer ACH or BTMD?

In the previous week, Accendra Health had 3 more articles in the media than biote. MarketBeat recorded 7 mentions for Accendra Health and 4 mentions for biote. biote's average media sentiment score of 0.94 beat Accendra Health's score of 0.25 indicating that biote is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accendra Health 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral biote 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PRPO or ACH?

Accendra Health has a consensus price target of $1.50, indicating a potential upside of 644.42%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts clearly believe Accendra Health is more favorable than Precipio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Precipio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Accendra Health 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80

Does the media prefer PIII or ACH?

In the previous week, Accendra Health had 6 more articles in the media than P3 Health Partners. MarketBeat recorded 7 mentions for Accendra Health and 1 mentions for P3 Health Partners. Accendra Health's average media sentiment score of 0.25 beat P3 Health Partners' score of 0.00 indicating that Accendra Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Accendra Health 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate RYOJ or ACH?

Accendra Health has a consensus price target of $1.50, suggesting a potential upside of 644.42%. Given Accendra Health's stronger consensus rating and higher possible upside, analysts plainly believe Accendra Health is more favorable than RYOJ. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RYOJ 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Accendra Health 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80

Which has higher valuation and earnings, RYOJ or ACH?

RYOJ has higher earnings, but lower revenue than Accendra Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RYOJ $9.34M 2.87 $120K N/A N/A Accendra Health $2.73B 0.01 -$1.10B -$3.91 N/A

Is DCGO or ACH more profitable?

Accendra Health has a net margin of -6.72% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets DocGo -65.29% -40.42% -24.81% Accendra Health -6.72% -4.02% -0.80%

Does the media refer more to DCGO or ACH?

In the previous week, Accendra Health had 6 more articles in the media than DocGo. MarketBeat recorded 7 mentions for Accendra Health and 1 mentions for DocGo. DocGo's average media sentiment score of 0.68 beat Accendra Health's score of 0.25 indicating that DocGo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Accendra Health 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Accendra Health (ACH) Competitors

$0.20 -0.10 (-32.41%)

As of 11/6/2026 03:58 PM Eastern

Compare

ACH vs. BTMD, PRPO, PIII, RYOJ, and DCGO

Should you buy Accendra Health stock or one of its competitors? Accendra Health's main competitors and comparable companies include biote (BTMD), Precipio (PRPO), P3 Health Partners (PIII), RYOJ (RYOJ), and DocGo (DCGO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Accendra Health compare to biote?

Accendra Health (NYSE:ACH) and biote (NASDAQ:BTMD) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

biote has lower revenue, but higher earnings than Accendra Health. biote is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accendra Health	$2.73B	0.01	-$1.10B	-$3.91	N/A
biote	$192.22M	0.20	$27.05M	-$0.10	N/A

biote has a net margin of -1.08% compared to Accendra Health's net margin of -6.72%. Accendra Health's return on equity of -4.02% beat biote's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accendra Health	-6.72%	-4.02%	-0.80%
biote	-1.08%	-8.84%	4.64%

21.7% of biote shares are owned by institutional investors. 2.3% of Accendra Health shares are owned by company insiders. Comparatively, 32.4% of biote shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Accendra Health has a beta of 1.6, suggesting that its share price is 60% more volatile than the broader market. Comparatively, biote has a beta of 1.73, suggesting that its share price is 73% more volatile than the broader market.

In the previous week, Accendra Health had 3 more articles in the media than biote. MarketBeat recorded 7 mentions for Accendra Health and 4 mentions for biote. biote's average media sentiment score of 0.94 beat Accendra Health's score of 0.25 indicating that biote is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accendra Health	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
biote	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Accendra Health presently has a consensus target price of $1.50, suggesting a potential upside of 644.42%. biote has a consensus target price of $2.50, suggesting a potential upside of 135.85%. Given Accendra Health's higher possible upside, analysts clearly believe Accendra Health is more favorable than biote.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
biote	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

biote beats Accendra Health on 12 of the 17 factors compared between the two stocks.

How does Accendra Health compare to Precipio?

Precipio (NASDAQ:PRPO) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

In the previous week, Accendra Health had 7 more articles in the media than Precipio. MarketBeat recorded 7 mentions for Accendra Health and 0 mentions for Precipio. Accendra Health's average media sentiment score of 0.25 beat Precipio's score of 0.00 indicating that Accendra Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Precipio	Neutral
Accendra Health	Neutral

Precipio has higher earnings, but lower revenue than Accendra Health. Precipio is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$24.05M	1.39	-$360K	-$0.64	N/A
Accendra Health	$2.73B	0.01	-$1.10B	-$3.91	N/A

10.5% of Precipio shares are owned by institutional investors. 16.6% of Precipio shares are owned by company insiders. Comparatively, 2.3% of Accendra Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Precipio has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Accendra Health has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

Accendra Health has a consensus price target of $1.50, indicating a potential upside of 644.42%. Given Accendra Health's stronger consensus rating and higher probable upside, analysts clearly believe Accendra Health is more favorable than Precipio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

Precipio has a net margin of -4.47% compared to Accendra Health's net margin of -6.72%. Accendra Health's return on equity of -4.02% beat Precipio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Precipio	-4.47%	-8.49%	-5.75%
Accendra Health	-6.72%	-4.02%	-0.80%

Summary

Accendra Health beats Precipio on 9 of the 15 factors compared between the two stocks.

How does Accendra Health compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

P3 Health Partners currently has a consensus target price of $17.00, suggesting a potential upside of 325.00%. Accendra Health has a consensus target price of $1.50, suggesting a potential upside of 644.42%. Given Accendra Health's higher probable upside, analysts clearly believe Accendra Health is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

P3 Health Partners has a beta of 1.81, meaning that its stock price is 81% more volatile than the broader market. Comparatively, Accendra Health has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

7.8% of P3 Health Partners shares are owned by institutional investors. 10.9% of P3 Health Partners shares are owned by company insiders. Comparatively, 2.3% of Accendra Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

P3 Health Partners has a net margin of -6.55% compared to Accendra Health's net margin of -6.72%. P3 Health Partners' return on equity of 0.00% beat Accendra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-6.55%	N/A	-16.40%
Accendra Health	-6.72%	-4.02%	-0.80%

In the previous week, Accendra Health had 6 more articles in the media than P3 Health Partners. MarketBeat recorded 7 mentions for Accendra Health and 1 mentions for P3 Health Partners. Accendra Health's average media sentiment score of 0.25 beat P3 Health Partners' score of 0.00 indicating that Accendra Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Accendra Health	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

P3 Health Partners has higher earnings, but lower revenue than Accendra Health. P3 Health Partners is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.02	-$147.95M	-$33.00	N/A
Accendra Health	$2.73B	0.01	-$1.10B	-$3.91	N/A

Summary

P3 Health Partners beats Accendra Health on 9 of the 16 factors compared between the two stocks.

How does Accendra Health compare to RYOJ?

RYOJ (NASDAQ:RYOJ) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

RYOJ has higher earnings, but lower revenue than Accendra Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RYOJ	$9.34M	2.87	$120K	N/A	N/A
Accendra Health	$2.73B	0.01	-$1.10B	-$3.91	N/A

RYOJ has a net margin of 0.00% compared to Accendra Health's net margin of -6.72%. RYOJ's return on equity of 0.00% beat Accendra Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RYOJ	N/A	N/A	N/A
Accendra Health	-6.72%	-4.02%	-0.80%

In the previous week, Accendra Health had 7 more articles in the media than RYOJ. MarketBeat recorded 7 mentions for Accendra Health and 0 mentions for RYOJ. Accendra Health's average media sentiment score of 0.25 beat RYOJ's score of 0.00 indicating that Accendra Health is being referred to more favorably in the news media.

Company	Overall Sentiment
RYOJ	Neutral
Accendra Health	Neutral

Accendra Health has a consensus price target of $1.50, suggesting a potential upside of 644.42%. Given Accendra Health's stronger consensus rating and higher possible upside, analysts plainly believe Accendra Health is more favorable than RYOJ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RYOJ	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

RYOJ has a beta of 4.77, suggesting that its share price is 377% more volatile than the broader market. Comparatively, Accendra Health has a beta of 1.6, suggesting that its share price is 60% more volatile than the broader market.

Summary

RYOJ beats Accendra Health on 6 of the 11 factors compared between the two stocks.

How does Accendra Health compare to DocGo?

DocGo (NASDAQ:DCGO) and Accendra Health (NYSE:ACH) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

DocGo has higher earnings, but lower revenue than Accendra Health. DocGo is trading at a lower price-to-earnings ratio than Accendra Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.08	-$182.40M	-$1.96	N/A
Accendra Health	$2.73B	0.01	-$1.10B	-$3.91	N/A

56.4% of DocGo shares are held by institutional investors. 5.1% of DocGo shares are held by company insiders. Comparatively, 2.3% of Accendra Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

DocGo has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Accendra Health has a beta of 1.6, suggesting that its stock price is 60% more volatile than the broader market.

Accendra Health has a net margin of -6.72% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
Accendra Health	-6.72%	-4.02%	-0.80%

DocGo presently has a consensus price target of $2.17, suggesting a potential upside of 784.35%. Accendra Health has a consensus price target of $1.50, suggesting a potential upside of 644.42%. Given DocGo's stronger consensus rating and higher possible upside, research analysts plainly believe DocGo is more favorable than Accendra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

In the previous week, Accendra Health had 6 more articles in the media than DocGo. MarketBeat recorded 7 mentions for Accendra Health and 1 mentions for DocGo. DocGo's average media sentiment score of 0.68 beat Accendra Health's score of 0.25 indicating that DocGo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Accendra Health	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

DocGo beats Accendra Health on 9 of the 16 factors compared between the two stocks.

Get Accendra Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACH vs. The Competition

Export

Metric	Accendra Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$15.63M	$10.60B	$7.76B	$22.98B
Dividend Yield	N/A	2.54%	2.47%	3.76%
P/E Ratio	-0.09	37.04	34.49	29.91
Price / Sales	0.01	2.10	8.23	3.34
Price / Cash	0.05	23.11	21.82	15.54
Price / Book	-0.03	3.86	4.53	3.77
Net Income	-$1.10B	$320.61M	$3.51B	$1.08B
7 Day Performance	-17.96%	-0.38%	-1.01%	-0.92%
1 Month Performance	-54.98%	0.83%	-4.45%	-0.66%
1 Year Performance	N/A	13.03%	2.63%	6.01%

Accendra Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACH Accendra Health	2.3717 of 5 stars	$0.20 -32.4%	$1.50 +644.4%	N/A	$15.63M	$2.73B	N/A	6,500	News Coverage Earnings Report Analyst Upgrade Gap Down
BTMD biote	4.2574 of 5 stars	$1.04 -15.4%	$2.50 +140.4%	-60.9%	$37.37M	$192.22M	9.46	223	News Coverage Positive News Earnings Report Gap Down
PRPO Precipio	0.5187 of 5 stars	$18.59 -5.0%	N/A	-6.9%	$33.28M	$24.05M	N/A	71	Upcoming Earnings Gap Down
PIII P3 Health Partners	2.2758 of 5 stars	$3.82 -6.8%	$17.00 +345.0%	-47.6%	$27.73M	$1.46B	N/A	320	News Coverage Upcoming Earnings Gap Up
RYOJ RYOJ	N/A	$2.33 -12.1%	N/A	N/A	$26.91M	$9.34M	N/A	313	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ACH) was last updated on 11/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Accendra Health (ACH) Competitors

ACH vs. BTMD, PRPO, PIII, RYOJ, and DCGO

How does Accendra Health compare to biote?

Summary

How does Accendra Health compare to Precipio?

Summary

How does Accendra Health compare to P3 Health Partners?

Summary

How does Accendra Health compare to RYOJ?

Summary

How does Accendra Health compare to DocGo?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACH vs. The Competition

Accendra Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Accendra Health (ACH) Competitors

ACH vs. BTMD, PRPO, PIII, RYOJ, and DCGO

How does Accendra Health compare to biote?

Which has higher valuation and earnings, ACH or BTMD?

Is ACH or BTMD more profitable?

Do institutionals and insiders hold more shares of ACH or BTMD?

Which has more volatility & risk, ACH or BTMD?

Does the media prefer ACH or BTMD?

Do analysts prefer ACH or BTMD?

Summary

How does Accendra Health compare to Precipio?

Does the media prefer PRPO or ACH?

Which has higher valuation and earnings, PRPO or ACH?

Do insiders and institutionals believe in PRPO or ACH?

Which has more risk & volatility, PRPO or ACH?

Do analysts recommend PRPO or ACH?

Is PRPO or ACH more profitable?

Summary

How does Accendra Health compare to P3 Health Partners?

Do analysts recommend PIII or ACH?

Which has more risk and volatility, PIII or ACH?

Do insiders & institutionals hold more shares of PIII or ACH?

Is PIII or ACH more profitable?

Does the media prefer PIII or ACH?

Which has stronger valuation and earnings, PIII or ACH?

Summary

How does Accendra Health compare to RYOJ?

Which has higher valuation and earnings, RYOJ or ACH?

Is RYOJ or ACH more profitable?

Does the media favor RYOJ or ACH?

Do analysts rate RYOJ or ACH?

Which has more volatility & risk, RYOJ or ACH?

Summary

How does Accendra Health compare to DocGo?

Which has higher valuation & earnings, DCGO or ACH?

Do institutionals and insiders believe in DCGO or ACH?

Which has more volatility and risk, DCGO or ACH?

Is DCGO or ACH more profitable?

Do analysts recommend DCGO or ACH?

Does the media refer more to DCGO or ACH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACH vs. The Competition

Accendra Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools